LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy.

Stakheev, Dmitry; Taborska, Pavla; Kalkusova, Katerina; Bartunkova, Jirina; Smrz, Daniel

Stakheev, Dmitry; Taborska, Pavla; Kalkusova, Katerina; Bartunkova, Jirina; Smrz, Daniel.

Afiliação

Stakheev D; Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic.
Taborska P; Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic.
Kalkusova K; Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic.
Bartunkova J; Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic.
Smrz D; Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic.

Pharmaceutics ; 14(12)2022 Dec 08.

Article em En | MEDLINE | ID: mdl-36559241

Palavras-chave

CD8+ T cells; LL-37; cancer; cellular immunotherapy; dendritic cells

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google